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Summary
Background. Sero-reactivity disclosure to blood donors is an important issue of public do-
main. The sensitivity of situation demands both confidential as well as trust laden atmosphere 
while notifying them. Our aim was to assess and analyze the response rate of sero-reactive 
donors towards post-donation notification and counselling. 
Material and methods. Donors reactive for any transfusion transmitted infections were no-
tified of their results and called to blood bank for counseling (January 2016 to December 2017). 
The notification process included one postal and two telephonic communications. Their privacy 
was maintained throughout the whole process. Responders were counseled by the medical officer 
and subsequently referred to the concerned specialty for further management. 
Results. Among 30,343 voluntary blood donors (96% males) 65.2% (n = 19 784) were re-
peat donors. Total 0.42% (n = 129) cases with reactive screening test results (0.30% HBV; 
0.06% HIV; 0.006% HCV; 0.04% syphilis and 0.006% malaria) were evaluated. Prevalence of 
HBV and HIV were higher among first time donors (0.61% and 0.12%) than in repeat donors 
(0.14% and 0.02%) respectively (p = 0.002). Overall 58% (n = 75/129) donors responded to 
notification and counseling. Response among repeat donors (67.5% [n = 27/40]) versus first 
time donors (54.0% [n = 48/89]) was better and statistically significant (p = 0.05). The re-
sponse rate for Malaria, HIV, Syphilis, HBV and HCV was 100%, 78%, 77%, 51% and 50%, 
respectively. Inaccurate donor demographics (wrong address and phone number) resulted in 
our inability to notify 11.6% (n = 15) cases. Major factors hindering the response rate were 
donors’ inability to be present for a post-test discussion either due to far distance (> 100 miles) 
and/or their busy schedule. 
Conclusion. Good response was noted among repeat blood donors. Donor education and re-
peated attempts to communicate with the sero-reactive donors would improve the response rate. 
Key words: Blood donor notification, transfusion transmitted infections,  
post-test discussion
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Streszczenie
Wstęp. Ujawnianie seroreaktywności u dawców krwi jest ważnym problemem zdrowia pub-
licznego. Jest to szczególna sytuacja wymagająca zarówno zachowania poufności, jak i atmo-
sfery zaufania w trakcie przekazywania tej informacji. Celem autorów była ocena i analiza 
odsetka odpowiedzi u  seropozytywnych dawców na powiadomienia i  rozmowy po donacji. 
Materiał i metody. Dawcy, u których stwierdzono seroreaktywność w odniesieniu do jakiego-
kolwiek zakażenia przenoszonego przez transfuzję, zostali powiadomieni o wynikach badania 
i wezwani do banku krwi na konsultację (w okresie od stycznia 2016 r. do grudnia 2017 r.). 
Proces powiadamiania obejmował jedną informację listowną i  dwie rozmowy telefoniczne. 
W ciągu całego procesu zachowano zasady prywatności i poufności. Osoby, które odpowiedziały 
na powiadomienie, odbywały poradę lekarską, a następnie były kierowane do odpowiedniego 
specjalisty w celu dalszego postępowania diagnostyczno-leczniczego. 
Wyniki. Spośród 30 343 dobrowolnych dawców krwi (96% mężczyzn) 65,2% (n = 19 784) 
oddawało krew wielokrotnie. Ogółem stwierdzono 0,42% (n = 129) przypadków z pozytyw-
nymi wynikami badań przesiewowych (0,30% HBV; 0,06% HIV; 0,006% HCV; 0,04% kiła 
i 0,006% malaria). Częstość występowania HBV i HIV była wyższa wśród osób, które oddawały 
krew po raz pierwszy [0,61% i 0,12%] niż w przypadku dawców wielokrotnych (odpowiednio 
0,14% i 0,02%; p = 0,002). Ogółem 58% (n = 75/129) dawców odpowiedziało na zgłoszenia 
i stawiło się na wizytę. Odpowiedź wśród dawców wielokrotnych (67,5% [n = 27/40]) była 
lepsza niż w przypadku osób oddających krew po raz pierwszy (54,0% [n = 48/89]), a różnica 
była statystycznie istotna (p = 0,05). Wskaźnik odpowiedzi u osób, u których wykryto malarię, 
HIV, syfilis, HBV i HCV wynosił odpowiednio 100%, 78%, 77%, 51% i 50%. Niedokładne 
dane demograficzne (zły adres i numer telefonu) spowodowały, że nie udało się powiadomić 
dawców w 11,6% [n = 15] przypadków. Głównymi czynnikami utrudniającymi szybkość odpo-
wiedzi były niemożność zgłoszenia się dawców na rozmowę po badaniu ze względu na odległość 
[> 100 mil] i/lub ich napięty harmonogram. 
Wniosek. Wśród wielokrotnych dawców krwi odnotowano wysoki wskaźnik odpowiedzi. 
Edukacja dawców i wielokrotne próby komunikacji z seropozytywnymi dawcami poprawiłyby 
wskaźnik odpowiedzi.
Słowa kluczowe: powiadomienie dawcy krwi, zakażenia przenoszone drogą transfuzji, 
rozmowa po badaniu
J. Transf. Med. 2018; 11: 144–150
Introduction
Receiving blood transfusion although be-
neficial imposes, quite often, a definitive risk of 
transfusion transmitted infections (TTI) for the 
recipients. National guideline mandates that safe 
blood is the universal right of all recipients and 
at least all donated blood be fully screened for in-
fectious agents such as Hepatitis B virus (HBV), 
Hepatitis C virus (HCV), Human immunodeficien-
cy virus (HIV), Syphilis and Malaria [1]. This will 
enhance blood safety and reduce sero-prevalence 
in donated blood. Blood transfusion services have 
a dual responsibility towards ensuring the safety of 
both donors as well as patients. Of all the aspects 
towards blood donor’s safety, their notification and 
post-donation counseling remains the most impor-
tant domain. Blood centers are now required to ob-
tain written consent prior to donation as to whether 
donors wish to be informed about a reactive test 
result and to direct the HIV reactive donors to 
Integrated Counseling and Testing Centers (ICTC) 
for disclosure, counseling and further workup. All 
the donors reactive for HBV, HCV, syphilis and/ 
/or malaria need to be appropriately informed 
and referred to the physician for their further 
management [2]. The sensitivity of the situation 
demands both a confidential as well as a trust laden 
atmosphere while notifying and counseling them, 
with the two-fold goal of primarily minimizing their 
disease burden and secondarily to reduce the risk 
of further transmission. Donor notification must 
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be done telephonically and by registered post 
for a one-on-one post-test discussion (PTD) and 
counseling as well as repeat sampling for confir-
matory tests. In our country there is a deficiency 
of both regional and/or national database to sub-
stantiate notification and counselling success rate 
among blood donors, more so due to fragmented 
management of blood transfusion services [3]. 
Our primary goal therefore was to assess and 
analyze the response rate of sero-reactive donors 
to post-donation notification and counselling at our 
establishment.
Materials and methods
Study design
This was an observational descriptive study 
performed at the department of Immunohemato-
logy and Blood Transfusion over a period of two 
years (January 2016 through December 2017). 
The protocol was approved by the Institutional 
Ethics Committee, prior to its commencement 
(IEC 104/2016). As per the department protocol 
informed consent (regarding disclosure of sero-
-reactivity) was obtained from all the donors prior 
to donation. All procedures performed in studies 
involving human participants were in accordance 
with the ethical standards of the institutional ethics 
committee and with the 1964 Helsinki declaration.
Donor measures
Information of all the voluntary blood donors 
was retrieved from the blood bank software (Easy 
Software Solutions, Ahmedabad, India). Donor 
measures included were: Donor type [First time 
donor (FTD); Repeat donor (RD)]; Gender; Age 
group; Spoken language (Kannada; Tulu; Others); 
Marital status and Education (Primary: up to class 
V completed; Secondary: up to class X completed; 
Higher Secondary: beyond class X).
Study methodology
Screening of blood donors’ samples was per-
formed using the routine Enzyme-Linked Immu-
nosorbent Assay (ELISA) testing of markers HIV, 
HBV, HCV as per the mandate of national guide-
lines [4]. Tests performed were ELISA (Biorad, 
France) towards HBV surface antigen (HBsAg) 
to detect HBV, anti-HCV to detect HCV, 4th gene-
ration kits to detect p24 antigen and glycoprotein 
antibodies against HIV, p-LDH malaria specific 
antigen towards detection of malarial parasites 
(Qualisa, Tulip Diagnostics, Goa, India) and syphi-
litic Reagin antibodies detection employing the 
RPR technique (CARBOGEN, Tulip Diagnostics, 
Goa, India). According to our department standard 
operating procedure (SOP), initial reactive (IR) re-
sult in screening was repeated in duplicate (where 
sample was tested two more times). If found repeat 
reactive (RR) by ELISA and/or one ELISA + Su-
pplementary test (such as Rapid) positive, these 
donors qualified for notification and counseling. 
The strategy of notifying was primarily by means 
of establishing an initial telephonic communication 
and a postal communication (within one week of 
detection). This followed a second telephone call 
(usually within 72 hours), if no response was heard 
from the initial telephonic communication. HIV 
reactive responders were referred to the Integra-
ted Counseling and Testing Center (ICTC) at our 
hospital for counseling and further confirmatory 
testing, while HBV, HCV, syphilis and malaria 
reactive donors were referred to the concerned 
specialties for their further management.
Donor notification process
In case of sero-reactive blood for any of the 
five tested markers, the unit was discarded in 
accordance to our department SOP and a registe-
red postal communication was established. After 
postal communication, all the donors were given 
a direct telephone call to arrange a post-test di-
scussion (PTD) face-to-face with the blood bank 
physician (BBP) at a  time convenient for both 
donors as well as BBP. PTD included ensuring 
that the donors understood the meaning of the 
test results, their implications on own health and 
meeting the concerned specialty (in case of HBV, 
HCV, Syphilis and Malaria) and ICTC (in case of 
HIV) respectively. During PTD ample care was 
taken to avoid ambiguity and information about the 
test results was delivered to the donors in their 
spoken language. Privacy of the donors’ informa-
tion was kept secure by keeping the notification 
file (including their details) in a safe place under 
the lock and direct supervision of the BBP only. On 
attempting the initial communication, if, we didn’t 
hear back from the donor, a  second telephonic 
call was attempted. Donors who were completely 
non-compliant were eventually kept in the “No-
-response cohort”. The reason for not attending 
the PTD was asked during the second telephone 
call and documented.
Statistical analysis
Data was entered in a spread sheet and finally 
analyzed using IBM SPSS Statistical package ver-
sion 20 (IBM, USA). Simple descriptive statistics 
were expressed as frequency distribution, mean 
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Table 1. Blood donor demographics notified in 2016–2017
Tabela 1. Dane demograficzne dawców krwi w latach 2016–2017
S. No Donor characteristics HBV 
N (%)
HIV 
N (%)
HCV 
N (%)
Syphilis 
N (%)
Malaria 
N (%)
Total
N (%)
1 Sero-reactive donors 94 (73) 18 (14) 2 (1.5) 13 (10) 2 (1.5) 129 (100)
2 Total responders 48 (51) 14 (78) 1 (50) 10 (77) 2 (100) 75 (58)
3 Types of donors:
a. FTD
b. RD
65 (69)
29 (31)
13 (72)
5 (28)
1 (50)
1 (50)
9 (69)
4 (31)
1 (50)
1 (50)
89 (69)
40 (31)
4 Age-group (years)
18–24
25–34
> 35
19 (20)
40 (43)
35 (37)
0 (0)
10 (56)
8 (44)
2 (100)
0 (0)
0 (0)
4 (31)
5 (38)
4 (31)
2 (100)
0 (0)
0 (0)
27 (21)
55 (43)
47 (36)
5 Gender
Male
Female
93 (99)
1 (1)
18 (100)
0 (0)
2 (100)
0 (0)
13 (100)
0 (0)
2 (100)
0 (0)
128 (99)
1 (1)
6 Marital status
Single
Married
27 (29)
67 (71)
6 (33)
12 (67)
1 (50)
1 (50)
5 (38)
8 (62)
2 (100)
0 (0)
41 (32)
88 (68)
7 Education
Primary
Secondary
Higher secondary
43 (46)
33 (35)
18 (19)
10 (56)
6 (33)
2 (11)
2 (100)
0 (0)
0 (0)
3 (23)
7 (54)
3 (23)
0 (0)
2 (100)
0 (0)
58 (45)
48 (37)
23 (18)
8 Spoken language
Kannada
Tulu
Others
58 (60.9)
21 (26.1)
15 (13.0)
12 (67)
5 (28)
1 (5)
1 (50)
0 (0)
1 (50)
9 (69)
4 (31)
0 (0)
2 (100)
0 (0)
0 (0)
82 (64)
30 (23)
17 (13)
± standard deviation and quantitative data was 
expressed as percentage. P value less than 0.05 
was considered to be statistically significant.
Results
Donor demographics and age-wise distri-
bution: Among 30,343 voluntary blood donors 
(96% males), 129 were sero-reactive for at least 
one out of five infectious markers. Mean age of 
sero-reactive donors was 32 ± 8.9 (18 to 58) 
years. On age-wise distribution majority 43% 
(n = 55/129) were in 25 to 34-year age group. 
Geographically majority were from Udupi district 
64% (n = 83/129) with their main spoken lan-
guage as Kannada. Overall 68 % (n = 88) were 
married and 45% (n = 58) had primary level of 
education (Tab. 1). 
Donor types and infection rate
Overall 65.2% (n = 19,784) were repeat do-
nors and 0.42% (n = 129) cases were sero-reactive 
for at least one out of five infectious markers 
(0.30% HBV; 0.06% HIV; 0.006% HCV; 0.04% 
syphilis and 0.006% malaria). There were 0.006% 
(n = 2/30,343) donors who showed co-infection 
including HIV + HBsAg and HIV + Syphilis each. 
For the ease of analysis both the scenarios were 
considered under HIV data only. Prevalence of 
HBV and HIV were higher among FTD (0.61% and 
0.12%) than in RD (0.14% and 0.02%).
Donors contacted and response rate
On first communication, only 88.4% (n  = 
= 114/129) could be contacted. Of the contacted 
donors 34.2% (n = 39/114) did not respond, citing 
mainly far distance (> 100 miles [n = 22/39]) 
and their busy schedule (n = 17/39) respectively. 
Additionally, only 58% (n = 75) responded to PTD 
and counseling with BBP (Fig. 1). Repeat com-
munication was attempted among the remaining 
11.6% (n = 15) donors who could not be contacted 
initially. Reasons for the “Could not be contacted” 
cohort of donors was mainly inaccurate donor 
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Figure 1. Flow Chart Depicting the Study Process & Results
Figure 2. Responders who attended the Concerned Specialty at our Hospital
details namely, illegible address and inaccurate 
mobile number. Response among RD 67.5% (n = 
= 27/40) was better as compared to the FTD 
54.0% (n = 48/89) (p = 0.05). The response rate 
for malaria, HIV, syphilis, HBV and HCV were 
100%, 78%, 77%, 51% and 50%, respectively. 
Majority attended the concerned specialty at our 
hospital itself (Fig. 2). 
Discussion
Donor notification is a daunting task and poses 
several challenges to the health care workers/
personnel. Some of the difficulties faced are donors 
entering their contact details inaccurately while 
filling their pre-donation forms (such as inaccurate 
postal address and/or wrong phone number). Other 
challenges being few donors do not respond to the 
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telephone calls attempted while, others hide their 
personal history of high risk behavior and/or activi-
ty mainly because of social stigma associated. Furt-
hermore, there are several deficiencies present in 
the existing policies such as poor linkages between 
blood centers with ICTCs and/or medical units, lack 
of uniformity in the format available for referral, 
untrained donor counselors and lack of uniformity 
in the content of the letter for communication to 
the sero-reactive donors. Additionally, loss of their 
follow up compounds the existing problem. 
Prevalence of TTI in India ranges from 1.8– 
–4%, 0.4–1.09%, 0.2–1%, and 0.05–0.9% for 
HBV, HCV, HIV, and syphilis, respectively [5]. 
Prevalence of TTI in the present study was lower 
when compared with the existing sero-prevalence 
studies from our country. Reasons for lower rate 
of TTI prevalence in our donor population could 
be explained due to higher percentage of repeat 
regular voluntary blood donors (65%) against 
the frequency of first time donors (35%) at our 
center. Additionally, our pre-donation deferral rate 
is nearly 11.5%. 
In an Indian study by Patel et al. 60.4% sero-
-reactive donors showed a  positive response 
following donor notification and counseling [6]. In 
another Indian study by Agarwal et al. (involving 
416 reactive donors), only 59.8% subjects attended 
counseling after knowing their reactive status [7]. 
Our results show a moderate response rate (58%) 
to the calls made to the sero-reactive donors. 
This may be attributed to a relatively lesser kno-
wledge and understanding among the donors about 
various infectious markers and/or the screening 
test results. Additionally, perceptions regarding 
screening tests may vary among donors based on 
their socio-cultural beliefs [8]. Sharma et al. found 
that many donors did not know about the window 
period in test results and felt that it was fine for 
them to donate blood even if they engaged in high 
risk behavior since their blood would be tested for 
infectious markers anyway and eventually discar-
ded if found reactive [9].
In the present study, we also found that 11.6% 
(n = 15) sero-reactive donors could not be con-
tacted and informed about abnormal test results. 
Incomplete or inaccurate demographic details 
provided by donors were the main reasons acco-
untable for this “Could not be contacted” cohort. 
Marker wise distribution for this cohort was HBV: 
HIV: HCV: syphilis: malaria — 12:2:1: 0:0. The 
number of sero-reactive donors in this “Could not 
be contacted” cohort was, however, smaller as 
compared to large numbers of the studies done by 
Kotwal et al. and Moyer et al. (49.4% and 65.52%) 
respectively [10, 11]. 
In summary, a good response among repeat 
blood donors was noted. Non-responders among 
HBV and HCV sero-reactive donors were 49% and 
50% respectively. Donor education and repeated 
attempts to communicate with the sero-reactive 
donors would improve the response rate. There is 
also a collective need to review the effectiveness 
of current donor deferral criteria which is still 
dependent on the goodwill of the donor regarding 
disclosure of his or her personal high risk behavior. 
More efforts are needed to improve donors’ under-
standing about various serological tests as well as 
ensuring that their accurate demographic details 
are gathered prior to donation.
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